Literature DB >> 8483829

Strategies for indirect computer-aided drug design.

G H Loew1, H O Villar, I Alkorta.   

Abstract

This review is intended to describe some of the methods and procedures used for computer-aided drug design when the structure of the macromolecular target is unknown, as is the case for CNS active drugs. Strategies and methods used in computer-aided design of drugs in such instances must be "indirect," i.e., focusing on the characterization of the ligands themselves. This situation is different from one in which the three-dimensional structure of the macromolecular target for a drug is known, for example, for drugs that are enzyme inhibitors, allowing "direct" characterization of ligand-receptor interactions. Two qualitatively different "indirect" approaches are described here. One, called 2D-QSAR, is briefly reviewed. It is based on delineating regression relationships between a specified biological end point and properties of the compounds eliciting it. The other, based on pharmacophore development, constitutes the main part of this review. Several levels of pharmacophore development are described, which differ in the extent to which they encompass fundamental molecular properties that are determinants of receptor recognition and activation. The strengths and limitations of each procedure are discussed and illustrated by examples. Two methods for obtaining model receptor structures are then briefly described. Both rely on the prior success of the indirect methods in obtaining ligand properties that modulate receptor recognition and activation. These emerging capabilities have the potential to bridge the gap between indirect and direct methods of drug design, since, if successful, the design process can continue in a direct mode using explicit characterization of drug-receptor interactions. Strategies for hypothesis validation and use of hypothesis for drug design and discovery are also briefly reviewed. The final sections of this review describe specific computational tools such as molecular mechanics and quantum mechanical methods used to characterize and identify relevant molecular properties and indicate some areas for future development of computational chemistry methods that could increase its effectiveness in the design of novel drugs.

Mesh:

Substances:

Year:  1993        PMID: 8483829     DOI: 10.1023/a:1018977414572

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  29 in total

1.  A MATHEMATICAL CONTRIBUTION TO STRUCTURE-ACTIVITY STUDIES.

Authors:  S M FREE; J W WILSON
Journal:  J Med Chem       Date:  1964-07       Impact factor: 7.446

2.  High directional Monte Carlo procedure coupled with the temperature heating and annealing as a method to obtain the global energy minimum structure of polypeptides and proteins.

Authors:  J K Shin; M S Jhon
Journal:  Biopolymers       Date:  1991-02-05       Impact factor: 2.505

3.  Theoretical study of the flexibility and solution conformation of the cyclic opioid peptides [D-Pen2,D-Pen5]enkephalin and [D-Pen2,L-Pen5]enkephalin.

Authors:  C Chew; H O Villar; G H Loew
Journal:  Mol Pharmacol       Date:  1991-04       Impact factor: 4.436

4.  The computer program LUDI: a new method for the de novo design of enzyme inhibitors.

Authors:  H J Böhm
Journal:  J Comput Aided Mol Des       Date:  1992-02       Impact factor: 3.686

5.  Compare-Conformer: a program for the rapid comparison of molecular conformers based on interatomic distances and torsion angles.

Authors:  I Kolossváry; W C Guida
Journal:  J Chem Inf Comput Sci       Date:  1992 May-Jun

Review 6.  Three-dimensional modelling of G protein-linked receptors.

Authors:  J Findlay; E Eliopoulos
Journal:  Trends Pharmacol Sci       Date:  1990-12       Impact factor: 14.819

7.  ALADDIN: an integrated tool for computer-assisted molecular design and pharmacophore recognition from geometric, steric, and substructure searching of three-dimensional molecular structures.

Authors:  J H Van Drie; D Weininger; Y C Martin
Journal:  J Comput Aided Mol Des       Date:  1989-09       Impact factor: 3.686

8.  Calculation of the total electrostatic energy of a macromolecular system: solvation energies, binding energies, and conformational analysis.

Authors:  M K Gilson; B Honig
Journal:  Proteins       Date:  1988

9.  MENTHOR, a database system for the storage and retrieval of three-dimensional molecular structures and associated data searchable by substructural, biologic, physical, or geometric properties.

Authors:  Y C Martin; E B Danaher; C S May; D Weininger
Journal:  J Comput Aided Mol Des       Date:  1988-04       Impact factor: 3.686

10.  Quantum chemical studies on molecular determinants for drug action.

Authors:  H Weinstein; R Osman; S Topiol; J P Green
Journal:  Ann N Y Acad Sci       Date:  1981       Impact factor: 5.691

View more
  10 in total

1.  Differentiation of delta, mu, and kappa opioid receptor agonists based on pharmacophore development and computed physicochemical properties.

Authors:  M Filizola; H O Villar; G H Loew
Journal:  J Comput Aided Mol Des       Date:  2001-04       Impact factor: 3.686

2.  Computer-assisted comparison of the structural and electronic dispositions of ebastine and terfenadine.

Authors:  V Segarra; M López; H Ryder; J M Palacios; D J Roberts
Journal:  Drug Saf       Date:  1999       Impact factor: 5.606

Review 3.  Pharmacophore-based discovery of ligands for drug transporters.

Authors:  Cheng Chang; Sean Ekins; Praveen Bahadduri; Peter W Swaan
Journal:  Adv Drug Deliv Rev       Date:  2006-09-26       Impact factor: 15.470

4.  The role of structure-based ligand design and molecular modelling in drug discovery.

Authors:  J P Tollenaere
Journal:  Pharm World Sci       Date:  1996-04

5.  Designing sedative/hypnotic compounds from a novel substructural graph-theoretical approach.

Authors:  E Estrada; A Peña; R García-Domenech
Journal:  J Comput Aided Mol Des       Date:  1998-11       Impact factor: 3.686

6.  Heuristic lipophilicity potential for computer-aided rational drug design.

Authors:  Q Du; G A Arteca; P G Mezey
Journal:  J Comput Aided Mol Des       Date:  1997-09       Impact factor: 3.686

Review 7.  Recent advances in ligand-based drug design: relevance and utility of the conformationally sampled pharmacophore approach.

Authors:  Chayan Acharya; Andrew Coop; James E Polli; Alexander D Mackerell
Journal:  Curr Comput Aided Drug Des       Date:  2011-03       Impact factor: 1.606

8.  Improved quantitative structure-activity relationship models to predict antioxidant activity of flavonoids in chemical, enzymatic, and cellular systems.

Authors:  Andrei I Khlebnikov; Igor A Schepetkin; Nina G Domina; Liliya N Kirpotina; Mark T Quinn
Journal:  Bioorg Med Chem       Date:  2006-11-29       Impact factor: 3.641

9.  In silico Screening and Evaluation of the Anticonvulsant Activity of Docosahexaenoic Acid-Like Molecules in Experimental Models of Seizures.

Authors:  Ali Gharibi Loron; Soroush Sardari; Jamshid Narenjkar; Mohammad Sayyah
Journal:  Iran Biomed J       Date:  2016-09-04

Review 10.  Computational methods in drug discovery.

Authors:  Sumudu P Leelananda; Steffen Lindert
Journal:  Beilstein J Org Chem       Date:  2016-12-12       Impact factor: 2.883

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.